Reviva Pharmaceuticals Holdings, Inc.

RVPH · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income-$4-$6-$6-$6
Dep. & Amort.$0$0$0$0
Deferred Tax$0$0$0$0
Stock-Based Comp.$0$0$1$1
Change in WC-$2$1-$3-$3
Other Non-Cash$0-$0-$0$0
Operating Cash Flow-$6-$5-$8-$9
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.-$0-$0-$0$0
Stock Issued$9$10$0$17
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0$0
Financing Cash Flow$8$10$0$17
Forex Effect$0$0$0$0
Net Chg. in Cash$3$5-$8$8
Supplemental Information
Beg. Cash$10$5$13$6
End Cash$13$10$5$13
Free Cash Flow-$6-$5-$8-$9
Reviva Pharmaceuticals Holdings, Inc. (RVPH) Financial Statements & Key Stats | AlphaPilot